063Survival in Rheumatoid Lung Disease is Longer in Patients Treated with Rituximab than in those Receiving Anti-Tumour Necrosis Factor Therapy

063Survival in Rheumatoid Lung Disease is Longer in Patients Treated with Rituximab than in those Receiving Anti-Tumour Necrosis Factor Therapy

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) Vol. 55; no. suppl_1; pp. i86 - i87
Main Authors: Iqbal, Kundan, Carty, Sara, Dawson, Julie, Woodhead, Felix, Young, Adam, Kelly, Clive
Format: Journal Article
Language:English
Published: 01-04-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/kew142.003